Veterinary Medicines

Finadyne Transdermal 50 mg/ml pour-on solution for cattle

Authorised
  • Flunixin meglumine
Download as PDF

Product identification

Medicine name:
Finadyne Transdermal 50 mg/ml pour-on solution for cattle
Finadyne transdermaal, 50 mg/ml pour-on oplossing voor runderen
Active substance:
  • Flunixin meglumine
Target species:
  • Cattle
Route of administration:
  • Topical use

Product details

Active substance and strength:
  • Flunixin meglumine
    83.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Pour-on solution
Withdrawal period by route of administration:
  • Topical use
    • Cattle
      • Meat and offal
        7
        day
      • Milk
        36
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM01AG90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:
  • High density polyethylene (HDPE) bottles with polypropylene (PP) closures which have a peelable foil laminate induction innerseal and a liner. The bottles are equipped with a graduated dosing chamber and are supplied individually in a cardboard carton.Container size: 100 ml
  • High density polyethylene (HDPE) bottles with polypropylene (PP) closures which have a peelable foil laminate induction innerseal and a liner. The bottles are equipped with a graduated dosing chamber and are supplied individually in a cardboard carton.Container size: 250 ml
  • High density polyethylene (HDPE) bottles with polypropylene (PP) closures which have a peelable foil laminate induction innerseal and a liner. The bottles are equipped with a graduated dosing chamber and are supplied individually in a cardboard carton.Container size: 1000 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet Nederland B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vet Pharma Friesoythe GmbH
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 113694
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0323/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 26/01/2022
Download

Summary of Product Characteristics

English (PDF)
Published on: 11/02/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."